how to come off semaglutide Semaglutide: Half of Users Stop Drug Within Year in 'Concerning' Drop Semaglutide: The Medicine That Helps

Sinha-Hikim I, et al

Precision medicine is already guiding trials for LRRK2 inhibitors, GCase modulators, and GLP-1 analogues, representing a shift toward therapies tailored to molecular etiology and patient-specific risk profiles

Specifically, carnosine can reduce telomere shortening rate possibly by protecting telomeres from damage, thereby contributing to the life-extension effect of carnosine (Shao et al

However, clinical evidence remains limited

3 It is associated with a high prevalence of cardiovascular risk factors including hyperlipidemia and vascular disease, as well as metabolic abnormalities including type 2 diabetes

muscle pain or weakness